Executive Director, Clinical Research - Neurodegeneration
Alnylam Pharmaceuticals · Posted Nov 13, 2026
- Cambridge, Massachusetts, United States +1 more
- Hybrid
- Full-time · Executive
- 10+ years
1–3 jobs· newest first
Hybrid · Full-time · Executive
$255K–$345KHybrid · Full-time · Director
$283K–$425K
+10K new in the last hour
Alnylam Pharmaceuticals · Posted Nov 13, 2026
Drive the pipeline forward through leadership of clinical development programs, focusing primarily on Huntington’s program.
The successful candidate’s primary role will be one of the clinical study leads working on the plasminogen program transitioning from Phase 2 to Phase 3. The Director will report directly into the program clinical development strategy lead who provides the clinical research oversight of the program.
$255,000—$345,000 USD
Lead the US Hematology Medical Affairs organization, providing strategic and scientific leadership across the US Hematology franchise.
The annual base pay for this position ranges from $283,386 to $425,080 Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles).